உயர் இரத்த அழுத்த இதழ்: திறந்த அணுகல்

Sick sinus syndrome is a complex arrhythmia disorder characterized by sinus node dysfunction, leading to various disturbances in heart rhythm. Among the potential complications associated with SSS, atrial fibrillation stands out as a significant concern. AF is the most common sustained arrhythmia encountered in clinical practice, and its association with SSS has long been recognized. In this article, we present the findings of a systematic meta-analysis that aims to delve into the impact of SSS on new-onset AF, AF recurrence, and AF progression. To conduct this metaanalysis, we conducted a thorough search of major electronic databases to identify relevant studies exploring the link between SSS and AF. Our inclusion criteria encompassed observational studies, cohort studies, and randomized controlled trials that reported data on the incidence of new-onset AF, AF recurrence, and AF progression in patients with SSS. Each study was carefully evaluated for quality and methodological rigor.

Heart failure remains a significant global health burden, necessitating effective congestion management to improve patient outcomes. This retrospective study aimed to compare the long-term effects of tolvaptan and loop diuretics in the control of congestion in HF patients. Medical claims data from a diverse group of HF patients treated with either tolvaptan or loop diuretics were analyzed over several years to assess their impact on two primary outcomes: time to HF rehospitalization and time to in-hospital death. The study cohort consisted of HF patients with documented congestion symptoms and diverse comorbidities, spanning different demographic profiles. The analysis included a comprehensive examination of medical claims data, enabling the assessment of long-term treatment effects.

Kidney transplantation is a life-saving procedure for individuals suffering from end-stage renal disease. Despite its potential to significantly improve patients' quality of life, it is not without complications. Transplant renal artery stenosis is one such vascular issue that may arise post-transplantation, posing a serious threat to the viability of the transplanted kidney and potentially leading to graft loss if left unaddressed. This article delves into the complexities of TRAS, its potential consequences on both the transplanted organ and the overall health of the recipient. Emphasizing the significance of timely and appropriate diagnosis and treatment, we highlight the crucial role of medical professionals in preserving successful kidney transplants and avoiding severe systemic repercussions. By shedding light on the challenges associated with TRAS, this article aims to raise awareness among healthcare practitioners, ultimately contributing to enhanced patient outcomes and improved long-term transplant success rates.

Benign intracranial hypertension (BIH), also known as idiopathic intracranial hypertension, is a neurological condition characterized by increased intracranial pressure without a clear cause. It is most commonly seen in young overweight women, although it can affect people of any age, gender, or body type. The symptoms of BIH may include severe headaches, pulsatile tinnitus (ringing in the ears), transient visual obscurations, double vision, nausea and vomiting. These symptoms are often worse upon waking up in the morning or after changes in posture, such as standing up. If left untreated, BIH can cause vision loss and permanent damage to the optic nerves.

Baroreflex activation therapy (BAT) is a novel treatment option for patients with heart failure that works by stimulating the body's natural baroreflex mechanism. This therapy involves the implantation of a device that sends electrical impulses to the baroreceptors located in the carotid arteries, which in turn signals the brain to regulate blood pressure and heart rate. In this article, we will discuss the benefits of BAT in patients with heart failure. A recent study published in the Journal of Cardiology aimed to evaluate the efficacy and safety of BAT in patients with cardiomyopathy, both with and without coronary artery disease (CAD). The study included 30 patients with ischemic or non-ischemic cardiomyopathy who received BAT over a 6-month period. The study's primary endpoints were changes in exercise capacity, quality of life and NTproBNP levels

Pseudohyperaldosteronism, also known as apparent mineralocorticoid excess syndrome (AME), is a rare genetic disorder that causes the body to produce excessive amounts of cortisol, leading to hypertension and hypokalemia. In some cases, certain medications, including azole antifungals, can also induce pseudohyperaldosteronism-mediated hypertension and hypokalemia. Hypertension, or high blood pressure, is a common condition affecting millions of people worldwide. While there are many factors that can contribute to hypertension, including lifestyle and genetic factors, pseudohyperaldosteronism-induced hypertension is caused by the overproduction of cortisol. Cortisol is a hormone produced by the adrenal glands that helps regulate the body's response to stress. When cortisol levels are too high, it can cause the body to retain sodium and excrete potassium, leading to fluid retention and increased blood pressure

Paroxysmal Atrial Fibrillation (PAF) is a type of atrial fibrillation that occurs in episodes, typically lasting less than 7 days. This condition is characterized by irregular and rapid heartbeats that originate in the atria of the heart. Although PAF may be asymptomatic in some patients, it can cause a range of symptoms, including chest pain, shortness of breath, fatigue and palpitations. PAF is a relatively common condition, affecting millions of people worldwide. It is more prevalent in older adults and the risk of developing PAF increases with age. The condition is also more common in people with underlying heart disease, such as hypertension, coronary artery disease and heart failure

Postrevascularization syndrome (PRS) is a condition that arises as a result of the restoration of normal blood flow to tissues after a prolonged period of ischemia, which is the deficiency of blood supply to an organ or tissue. PRS is characterized by a range of injuries, both local and systemic, that can lead to serious complications if not treated promptly.